Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM

Data ReadoutpositivePositive

AI Analysis

Summary

Sana Biotechnology published 14-month results from its diabetes cell therapy program in the New England Journal of Medicine, demonstrating clinical progress in the development of its cell-based therapeutic approach.

Clinical Trial Data

Outcome Details

14-month diabetes cell therapy results published in NEJM

Importance:7/10

Sentiment:

0.70

cell therapydiabetesclinical datapeer-reviewed publication

Related Companies

$SANA

Read the original article

Published by yahoo_finance on July 16, 2026 9:11 PM

Read Original